DUBLIN, Aug. 27, 2026 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) ("Jazz Pharmaceuticals") announced the pricing of $1.1 billion aggregate principal amount of 1.875% exchangeable senior notes due 2032 (the "notes") in a private offering (the "offering") by Jazz Investments I...
Hence then, the article about jazz pharmaceuticals announces pricing of upsized private offering of 1 1 billion of 1 875 exchangeable senior notes due 2032 and concurrent ordinary share repurchases was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( Jazz Pharmaceuticals Announces Pricing of Upsized Private Offering of $1.1 Billion of 1.875% Exchangeable Senior Notes due 2032 and Concurrent Ordinary Share Repurchases )
Also on site :
- Garth Brooks’ Daughter Receives Backlash for Her Dolly Parton Tribute
- Dollywood CEO Makes One Thing Clear About the Park After Dolly Parton’s Death
- Aryna Sabalenka’s Sheer US Open Dress Wasn’t the Only Thing Catching Eyes